about
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisComparison of seven tests for high-grade cervical intraepithelial neoplasia in women with abnormal smears: the Predictors 2 study.Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With Men.Human papillomavirus (HPV) in young women in Britain: Population-based evidence of the effectiveness of the bivalent immunisation programme and burden of quadrivalent and 9-valent vaccine types.Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study.Alternative HER/PTEN/Akt pathway activation in HPV positive and negative penile carcinomasEarly consumption of peanuts in infancy is associated with a low prevalence of peanut allergy.Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial.Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical recordsPrognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study.13. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010.Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.HPV Serology Testing Confirms High HPV Immunisation Coverage in England.Assessing Peanut Consumption in a Population of Mothers and Their Children in the UKContinuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study.Comparing the performance of six human papillomavirus tests in a screening populationp63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.Declining genital Warts in young women in england associated with HPV 16/18 vaccination: an ecological study.Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England.Attendance of MSM at Genitourinary Medicine services in England: implications for selective HPV vaccination programme (a short communication).Decline in genital warts diagnoses among young women and young men since the introduction of the bivalent HPV (16/18) vaccination programme in England: an ecological analysis.Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 year-old females by area-level deprivation score, England, 2008 to 2011.A surveillance model for skin cancer in organ transplant recipients: a 22-year prospective study in an ethnically diverse population.Melanoma in organ transplant recipients: clinicopathological features and outcome in 100 cases.Characteristics of HPV infection over time in European women who are HIV-1 positive.Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.Single negative colposcopy: is it enough to rule out high-grade disease?Effect of baseline serum vitamin D levels on aromatase inhibitors induced musculoskeletal symptoms: results from the IBIS-II, chemoprevention study using anastrozole.A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer.Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.Predictive Value of Symptoms for Ovarian Cancer: Comparison of Symptoms Reported by Questionnaire, Interview, and General Practitioner NotesThe Impact of the National HPV Vaccination Program in England Using the Bivalent HPV Vaccine: Surveillance of Type-Specific HPV in Young Females, 2010-2016Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017Epidemiology of genital warts in the British population: implications for HPV vaccination programmesDeclines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017HPV vaccination of gay, bisexual and other men who have sex with men in sexual health and HIV clinics in England: vaccination uptake and attendances during the pilot phase
P50
Q28084924-454728A4-07ED-45DF-A09D-225E66E44755Q30423690-6B319BA2-3FAB-4BDF-AA46-6B3EF58E36ABQ33602635-B73F17BE-6941-40D4-A03D-D0560553975DQ33774640-D171CE68-E722-4A91-B1C3-3265174C6239Q33834332-A20824A9-61D5-404E-BE18-D83CC7F51641Q33846990-F061A820-4918-408F-895E-0BFF89B23699Q34014591-1AD3088B-CB2A-4630-9D01-B4937AD6123FQ34231754-43DC8B4D-E239-492C-BFE5-B19AC9D8A069Q34740050-666A9F59-5BE1-4BE9-842F-64A8BB1078EAQ34962331-0450F93C-48C9-4CFD-9BF5-67257E6879B9Q35654696-64F022CA-7514-4AD1-B979-5959173B078FQ35832300-94FBA2F7-FF85-459E-9FEC-E388E8ABDA71Q35950913-9980043E-EE46-4FFA-B657-5AFD07CB15DCQ36404939-2EF4E93A-7C6C-4E4F-91FF-56DEEA0C9D3EQ36602973-0A58A0FE-6317-413F-8170-C84C5B2BAC14Q36663594-38BA73D6-270D-4D7B-8BB5-6687116E1BBDQ36694173-A17DACD3-6C17-4628-8E1B-2781FAF37C36Q36866311-AC92E73C-A8A3-4848-BF3F-9A5427382B4BQ37213048-285FA136-5F31-402D-980E-EEA633E5199BQ37503936-B6331F19-C385-4523-8AB2-FFE0319D086DQ38916373-FA0EEA1A-6EFC-4871-A94E-DEAAB23B00A4Q39640508-0B062554-4893-4B07-91BC-F3D6F65CCA47Q41655617-35FB9AE2-D012-43DE-B6DE-84B6C1AC345EQ42241593-F6256074-3E8D-4642-B754-743F5336ACD5Q42514247-EB4EC17B-EA5C-46A2-BEFF-9919A1A46814Q43762900-2BEC433C-BFBB-4811-B294-196FFA222DF2Q44325641-F00D1D78-9015-493A-AF29-18EC2321B928Q44371959-F5E941D4-FD1C-449A-B338-09139CEE8330Q44945272-C3FC4A99-00DC-49D8-BF7F-40FEC96E0759Q45717212-7BCD13F4-37F5-4AAE-BA05-00922C44C8C1Q45742284-45C96B98-94CF-48D4-A0FA-51075319FF9DQ51895139-3CA109C3-052A-44B8-B36A-4EBD8766810BQ53231431-215AB8B7-ACD4-4713-BF89-4A27EA54CD87Q57414773-363E9F1D-BFCA-4038-86C9-F9B4B92BB1C9Q59358502-3408CCC3-0B5E-4348-91E0-4E5E06D83497Q64118658-20C7F495-A963-4BA2-8030-1A8E6C21F68AQ91361100-82EA09DC-B8D3-4E88-A268-4B13E49E71B2Q91361106-C9694A90-BC02-42AC-933F-802C3D1C03D9Q91556945-9F42160D-9DE1-48C6-9130-11210CC29633
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
David Mesher
@ast
David Mesher
@en
David Mesher
@es
David Mesher
@nl
David Mesher
@sl
type
label
David Mesher
@ast
David Mesher
@en
David Mesher
@es
David Mesher
@nl
David Mesher
@sl
prefLabel
David Mesher
@ast
David Mesher
@en
David Mesher
@es
David Mesher
@nl
David Mesher
@sl
P106
P1153
13805527900
P21
P31
P496
0000-0001-9163-6757